FAQ
Everything you need to know for confident, comfortable screening from home
Colosafe® detects altered DNA from colorectal cancer cells that naturally shed into your stool. This advanced DNA technology can identify cancer markers early, often before symptoms develop.
The test uses a highly sensitive laboratory method called polymerase chain reaction (PCR) to detect hypermethylated syndecan-2 (SDC2) DNA in a stool sample. A positive result is returned if SDC2 methylation is detected, indicating a higher risk of bowel cancer.
Colosafe® is recommended for adults at average risk of bowel cancer, those with a family history of the disease, or anyone experiencing symptoms that concern them.
Healthcare professionals can now order Colosafe® directly from Eurofins Biomnis. To place an order, please visit our How To Order page or contact Eurofins Biomnis at sales@ctie.eurofinseu.com
Colosafe® is non‑invasive and there are no physical risks from collecting a small stool sample at home. As with any screening test, false positives and false negatives can occur. A positive Colosafe result should be followed by colonoscopy.
A positive result means DNA changes have been detected that require further investigation. Your doctor will receive your results and will discuss the recommended next steps with you, which typically involves a follow-up colonoscopy.
A negative result provides 99.8% confidence that you don't have bowel cancer1. We recommend retesting every 2-3 years to maintain your peace of mind.
No preparation needed. Just follow the simple instructions in the kit received from your healthcare professional when you're ready to collect your sample.